NKGen Biotech, Inc.

EDGAR

Market value is not computed: no listed ticker is recorded for this company.

29 filing records in this dataset, filed from 2021-02-23 to 2026-02-26. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Latest quarter

Revenue

0 USD

2023 Q4 · USD

Exact inputs and evidence

Operating cash flow

-6.94 million USD

2023 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -21948000 USD Source
  • Operating Cash Flow: -15009000 USD Source

Free cash flow

-6.94 million USD

2023 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -21948000 USD Source
  • Operating Cash Flow: -15009000 USD Source
  • Capital Expenditure: 0 USD Source
  • Capital Expenditure: 0 USD Source
Cash and cash equivalents
6 thousand USD Source
Exact value

6000 USD

Long-term debt including current maturities
Not available
Shares outstanding
51.3 million shares Source
Exact value

51306712 shares

Reported share-count change

129.16% · 28.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 22388976 shares · 2024-03-31· Source
  • 51306712 shares · 2025-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-23.6 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence
  • Net income: -16088000 USD · 2024-04-01 – 2024-06-30 Source
  • Net income: 6598000 USD · 2024-07-01 – 2024-09-30 Source
  • Net income: -44286000 USD · 2024-01-01 – 2024-12-31 Source
  • Net income: -14872000 USD · 2024-01-01 – 2024-09-30 Source
  • Net income: 15350000 USD · 2025-01-01 – 2025-03-31 Source

Operating cash flow

-19.6 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence
  • Operating cash flow: -10033000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -4034000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -13928000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -10033000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -20881000 USD · 2024-01-01 – 2024-12-31 Source
  • Operating cash flow: -13928000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -2800000 USD · 2025-01-01 – 2025-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-02-26.

Financial data available through: 2023-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2023-12-31
  • Operating income: 3 of 11 periods available· newest 2023-12-31
  • Net income: 3 of 11 periods available· newest 2023-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2023-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2023-12-31
  • Total assets: 3 of 11 periods available· newest 2023-12-31
  • Total liabilities: 3 of 11 periods available· newest 2023-12-31
  • Current assets: 3 of 11 periods available· newest 2023-12-31
  • Current liabilities: 3 of 11 periods available· newest 2023-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2023-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -100%

    Prior period

    USD 77,000

    –

    Current period

    USD 0

    –

    Exact inputs and evidence

    0 − 77000 = -77000 USD

    77000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    0 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −USD 56.2 million

    Prior period

    −USD 26.75 million

    –

    Current period

    −USD 82.95 million

    –

    Exact inputs and evidence

    -82954000 − -26754000 = -56200000 USD

    -26754000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -82954000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 609,000

    Prior period

    −USD 22.56 million

    –

    Current period

    −USD 21.95 million

    –

    Exact inputs and evidence

    -21948000 − -22557000 = 609000 USD

    -22557000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -21948000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -100%

    Prior period

    USD 101,000

    –

    Current period

    USD 0

    –

    Exact inputs and evidence

    0 − 101000 = -101000 USD

    101000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    0 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

  • Revenue USD 0
  • Operating costs Derived USD 29.75 million
  • Operating income −USD 29.75 million
  • Tax, interest and other Derived USD 53.21 million
  • Net income −USD 82.95 million

Cash

  • Operating cash flow −USD 21.95 million
  • Capital expenditure USD 0
  • Free cash flow Derived −USD 21.95 million

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2021 Operating loss: operating costs were 5,232% of revenue.
  • 2022 Operating loss: operating costs were 31,718% of revenue.
  • 2023 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2021 2021-01-01 – 2021-12-31426000 22287000 Derived -21861000 1404000 Derived -23265000 -19951000 Derived
Source
2022 2022-01-01 – 2022-12-3177000 24423000 Derived -24346000 2408000 Derived -26754000 -22658000 Derived
Source
2023 2023-01-01 – 2023-12-310 29746000 Derived -29746000 53208000 Derived -82954000 -21948000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2023
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.460.1K345.1K230.0K115.0K0.0202120222023
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Revenue426000
2022Revenue77000
2023Revenue0

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2023
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8%-21%-50%-79%-108%202120222023
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2021Year over yearNo prior comparable period
2022Year over year-81.9%
2023Year over year-100%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -31,618.2% 2022
Net margin -34,745.5% 2022
Free cash flow margin -29,426% 2022
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2,780%-7,297%-17,373%-27,449%-37,525%2021-12-3120222023
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2021-12-31Operating marginNot reported
2022Operating margin-31,618.2%
2023Operating marginNot reported
2021-12-31Net marginNot reported
2022Net margin-34,745.5%
2023Net marginNot reported
2021Free cash flow margin-4,683.3%
2022Free cash flow margin-29,426%
2023Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -21.9M 2023
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.8M-4.7M-11.3M-17.8M-24.4M202120222023
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Operating cash flow-19548000
2022Operating cash flow-22557000
2023Operating cash flow-21948000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -21.9M 2023
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.8M-4.8M-11.3M-17.9M-24.5M202120222023
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2021Free cash flow-19951000
2022Free cash flow-22658000
2023Free cash flow-21948000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

456.1% 2023
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.493%369%246%123%0%202120222023
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2021Liabilities / assets310.6%
2022Liabilities / assets90.4%
2023Liabilities / assets456.1%

Current assets to current liabilities

Current assets divided by current liabilities.

0.05× 2023
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.05×0.04×0.03×0.01×0.00×202120222023
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2021Current assets / current liabilities0.01×
2022Current assets / current liabilities0.02×
2023Current assets / current liabilities0.05×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2021 2021-01-01 – 2021-12-31
−USD 23.27 million
Exact value

Exact value: -23265000 USD

2021-01-01 – 2021-12-31: -23265000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.55 million
Exact value

Exact value: -19548000 USD

2021-01-01 – 2021-12-31: -19548000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 403,000
Exact value

Exact value: 403000 USD

2021-01-01 – 2021-12-31: 403000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.95 million
Calculation and evidence

-19548000 − 403000 USD

Exact free cash flow: -19951000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-28 – 2021-12-31
−USD 990,638
Exact value

Exact value: -990638 USD

2021-01-28 – 2021-12-31: -990638 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.52 million
Exact value

Exact value: -1523725 USD

2021-01-28 – 2021-12-31: -1523725 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2022 2022-01-01 – 2022-12-31
−USD 26.75 million
Exact value

Exact value: -26754000 USD

2022-01-01 – 2022-12-31: -26754000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 22.56 million
Exact value

Exact value: -22557000 USD

2022-01-01 – 2022-12-31: -22557000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 101,000
Exact value

Exact value: 101000 USD

2022-01-01 – 2022-12-31: 101000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 22.66 million
Calculation and evidence

-22557000 − 101000 USD

Exact free cash flow: -22658000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 82.95 million
Exact value

Exact value: -82954000 USD

2023-01-01 – 2023-12-31: -82954000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.95 million
Exact value

Exact value: -21948000 USD

2023-01-01 – 2023-12-31: -21948000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2023-01-01 – 2023-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.95 million
Calculation and evidence

-21948000 − 0 USD

Exact free cash flow: -21948000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

29 filings · 1,004 latest values · 1,004 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001845459, 1845459, edgar:1845459

Also known as GRAF ACQUISITION CORP. IV, Graf Acquisition Corp. IV, NKGen Biotech, Inc., NKGen Biotech, Inc.